Bank of New York Mellon’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.9M Buy
2,282,161
+50,400
+2% +$603K 0.01% 1358
2026
Q1
$13.4M Sell
2,231,761
-29,164
-1% -$219K ﹤0.01% 1765
2025
Q4
$16.2M Sell
2,260,925
-1,311,030
-37% -$10.4M ﹤0.01% 1653
2025
Q3
$38.1M Sell
3,571,955
-7,709
-0.2% -$75.7K 0.01% 1180
2025
Q2
$34.7M Sell
3,579,664
-104,943
-3% -$1.08M 0.01% 1206
2025
Q1
$54.9M Sell
3,684,607
-118,058
-3% -$1.82M 0.01% 912
2024
Q4
$56.7M Sell
3,802,665
-149,081
-4% -$2.43M 0.01% 930
2024
Q3
$75.6M Sell
3,951,746
-22,723
-0.6% -$471K 0.01% 783
2024
Q2
$82.3M Sell
3,974,469
-21,940
-0.5% -$436K 0.02% 740
2024
Q1
$75.1M Sell
3,996,409
-127,985
-3% -$2.2M 0.01% 804
2023
Q4
$59.5M Buy
4,124,394
+1,208,715
+41% +$16.4M 0.01% 932
2023
Q3
$50.6M Sell
2,915,679
-79,092
-3% -$1.65M 0.01% 968
2023
Q2
$62.3M Sell
2,994,771
-2,452,065
-45% -$53.3M 0.01% 886
2023
Q1
$128M Sell
5,446,836
-47,456
-0.9% -$1.27M 0.03% 519
2022
Q4
$153M Sell
5,494,292
-3,572,012
-39% -$91.3M 0.04% 439
2022
Q3
$212M Buy
9,066,304
+834,392
+10% +$25.2M 0.05% 339
2022
Q2
$278M Sell
8,231,912
-198,044
-2% -$6.94M 0.06% 275
2022
Q1
$294M Buy
8,429,956
+99,856
+1% +$3.41M 0.06% 306
2021
Q4
$254M Buy
8,330,100
+3,031,313
+57% +$98.7M 0.05% 363
2021
Q3
$174M Buy
5,298,787
+1,058,652
+25% +$33.9M 0.03% 460
2021
Q2
$128M Buy
+4,240,135
New +$140M 0.02% 587

Other funds holding OGN

Bank of New York Mellon's OGN Position: Q2 2026 in Review

Bank of New York Mellon increased its Organon & Co (OGN) stake by 2.3% in Q2 2026, buying an estimated $603K and bringing the position to 2,282,161 shares worth $30.9M. The position accounts for 0.01% of the portfolio, ranked #1358.

Bank of New York Mellon first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $294M in Q1 2022. 391 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Bank of New York Mellon held 2,282,161 shares of Organon & Co worth $30.9M as of Q2 2026.
  • Bank of New York Mellon bought 50,400 Organon & Co shares in Q2 2026, an estimated $603K.
  • Organon & Co made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1358 holding.
  • Bank of New York Mellon first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Bank of New York Mellon's Organon & Co position peaked at $294M in Q1 2022.
  • 391 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.